Cargando…
Specific immunotherapy of MUC1-positive adenocarcinomas with a recombinant vaccinia virus expressing MUC1 and IL-2
Autores principales: | Bizouarne, N, Squiban, P, Acres, B, Balloul, JM, Ohresser, MA, Figlin, R, Belldegrun, A, Herrman, R, Rochlitz, C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300517/ http://dx.doi.org/10.1186/bcr334 |
Ejemplares similares
-
Metastatic Breast Tumour Regression Following Treatment by a
Gene-Modified Vaccinia Virus Expressing MUC1 and IL-2
por: Scholl, Susy, et al.
Publicado: (2003) -
Expression of MUC1 and MUC4 in Gallbladder Adenocarcinoma
por: Kim, Su-Mi, et al.
Publicado: (2012) -
Latest developments in MUC1 immunotherapy
por: Taylor-Papadimitriou, Joyce, et al.
Publicado: (2018) -
MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance
por: Betge, Johannes, et al.
Publicado: (2016) -
Advances in MUC1-Mediated Breast Cancer Immunotherapy
por: Li, Zhifeng, et al.
Publicado: (2022)